These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7658060)

  • 1. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection.
    Bélec L; Dupré T; Prazuck T; Tévi-Bénissan C; Kanga JM; Pathey O; Lu XS; Pillot J
    J Infect Dis; 1995 Sep; 172(3):691-7. PubMed ID: 7658060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cervicovaginal humoral immunity in clinically asymptomatic (CDC A1 and A2 category) patients with HIV-1 and HIV-2 infection.
    Bélec L; Tévi-Bénissan C; Dupré T; Mohamed AS; Prazuck T; Gilquin J; Kanga JM; Pillot J
    J Clin Immunol; 1996 Jan; 16(1):12-20. PubMed ID: 8926281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women.
    Lu XS; Bélec L; Pillot J
    J Infect Dis; 1993 May; 167(5):1189-92. PubMed ID: 8486953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T-lymphotropic virus type I excretion and specific antibody response in paired saliva and cervicovaginal secretions.
    Belec L; Jean Georges A; Hallouin MC; Si Mohamed A; Morand-Joubert L; Georges-Courbot MC
    AIDS Res Hum Retroviruses; 1996 Jan; 12(2):157-167. PubMed ID: 8834466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection.
    Bélec L; Tévi-Bénissan C; Lu XS; Prazuck T; Pillot J
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):719-29. PubMed ID: 7576932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased cervicovaginal production of both IgA1 and IgA2 subclasses in women with AIDS.
    Belec L; Meillet D; Gaillard O; Prazuck T; Michel E; Ngondi Ekome J; Pillot J
    Clin Exp Immunol; 1995 Jul; 101(1):100-6. PubMed ID: 7621578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects.
    Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
    AIDS Res Hum Retroviruses; 1999 Oct; 15(15):1365-76. PubMed ID: 10515152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervicovaginal synthesis of IgG antibodies to the immunodominant 175-199 domain of the surface glycoprotein gp46 of human T-cell leukemia virus type I.
    Bélec L; Georges-Courbot MC; Georges A; Mohamed AS; Londos-Gagliardi D; Hallouin MC; Hocini H; Guillemain B
    J Med Virol; 1996 Sep; 50(1):42-9. PubMed ID: 8890040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominate HIV1-specific IgG activity in various mucosal compartments of HIV1-infected individuals.
    Lü FX
    Clin Immunol; 2000 Oct; 97(1):59-68. PubMed ID: 10998318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk papillomavirus infection is associated with altered antibody responses in genital tract: non-specific responses in HPV infection.
    Bard E; Riethmuller D; Meillet D; Prétet JL; Schaal JP; Mougin C; Seillès E
    Viral Immunol; 2004; 17(3):381-9. PubMed ID: 15357904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervicovaginal anti-HIV antibodies in index women from HIV-discordant, exclusively heterosexual, couples.
    Bélec L; Prazuck T; Payan C; Mohamed AS; Cancre N; Hocini H; Malkin JE; Pillot J
    Viral Immunol; 1996; 9(3):155-8. PubMed ID: 8890473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients.
    Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
    J Immunol Methods; 1999 Jan; 222(1-2):111-24. PubMed ID: 10022378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.
    Fiore JR; Laddago V; Lepera A; La Grasta L; Di Stefano M; Saracino A; Lopalco P; Pastore G; Angarano G
    New Microbiol; 2000 Jan; 23(1):85-92. PubMed ID: 10946410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.
    Bélec L; Ghys PD; Hocini H; Nkengasong JN; Tranchot-Diallo J; Diallo MO; Ettiègne-Traore V; Maurice C; Becquart P; Matta M; Si-Mohamed A; Chomont N; Coulibaly IM; Wiktor SZ; Kazatchkine MD
    J Infect Dis; 2001 Dec; 184(11):1412-22. PubMed ID: 11709783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG subclass distribution in serum and various mucosal fluids of HIV type 1-infected subjects.
    Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
    AIDS Res Hum Retroviruses; 2000 Apr; 16(6):583-94. PubMed ID: 10777149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New method for quantifying anti-HIV1-gp160 antibodies in saliva, cervicovaginal secretions, and serum of infected women.
    Lü FX
    J Clin Lab Anal; 2000; 14(4):188-92. PubMed ID: 10906772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1.
    Williams SB; Flanigan TP; Cu-Uvin S; Mayer K; Williams P; Ettore CA; Artenstein AW; Duerr A; VanCott TC
    Clin Infect Dis; 2002 Sep; 35(5):611-7. PubMed ID: 12173138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a high sensitive immunoenzymatic assay to establish the origin of immunoglobulins in female genital secretions.
    Bard E; Riethmuller D; Biichlé S; Meillet D; Prétet JL; Mougin C; Seillès E
    J Immunoassay Immunochem; 2002; 23(2):145-62. PubMed ID: 12033640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal humoral immune response to hepatitis C virus E1/E2 surface glycoproteins and HCV shedding in saliva and cervicovaginal fluids from chronically HCV-infected patients.
    Bélec L; Legoff J; Si-Mohamed A; Bloch F; Mbopi Keou FX; Becquart P; Matta M; Prazuck T; Petite JP; Gutmann L; Payan C
    J Hepatol; 2003 Jun; 38(6):833-42. PubMed ID: 12763378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV Types 1 and 2.
    Mbopi-Kéou FX; Bélec L; Dalessio J; Legoff J; Grésenguet G; Mayaud P; Brown DW; Morrow RA
    Clin Diagn Lab Immunol; 2003 May; 10(3):388-93. PubMed ID: 12738636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.